Technology-Enabled Remote Hypertension Management To Advance Health Equity
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hypertension
- Sponsor
- Atman Health, Inc
- Enrollment
- 1500
- Primary Endpoint
- Difference in SBP change
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The primary objective of this study is to reliably estimate the difference in blood pressure control of a technology-enabled solution for blood pressure (BP) management over usual care. The study will also assess patient and provider satisfaction with the solution. Finally, the investigators will estimate the economic impact of the intervention in terms of resource utilization.
Detailed Description
The study design is a non-blinded pragmatic cluster-randomized controlled trial with a single intervention. Participants with uncontrolled hypertension will be identified from a randomly selected group of primary care clinics. Participants from half of the clinics will be enrolled in the intervention arm while the others will receive usual care. Participants in the intervention arm will undergo a series of software-driven medication initiation and titration steps until they reach a blood pressure target of systolic blood pressure \< 130 mmHg and diastolic blood pressure \< 80 mmHg. Participants will be subsequently monitored for up to 12 more months.
Investigators
Eligibility Criteria
Inclusion Criteria
- •18 years - 100 years
- •uncontrolled hypertension: as defined as SBP \> 140 or DBP \> 90 on 2 successive clinic visits
Exclusion Criteria
- •hearing impaired
- •visually impaired
- •cognitively impaired
- •hospice care
- •on hemodialysis at enrollment
- •New York Heart Association Class IV heart failure
Outcomes
Primary Outcomes
Difference in SBP change
Time Frame: 6 months after enrollment
Difference in mean change in systolic blood pressure (SBP)
Secondary Outcomes
- Difference in DBP change(6 months after enrollment)
- HEDIS proportion(6 months after enrollment)